Endocrinology in the time of COVID-19.
作者信息
Arlt Wiebke, Dekkers Olaf M, Léger Juliane, Semple Robert K
机构信息
Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, UK.
Department of Clinical Epidemiology, Leids Universitair Medisch Centrum, Centrum voor Humane en Klinische Genetica, Leiden, the Netherlands.
出版信息
Eur J Endocrinol. 2020 Jul;183(1):E1-E2. doi: 10.1530/EJE-20-0386.
Abstract
摘要
相似文献
1
Endocrinology in the time of COVID-19.新冠疫情时期的内分泌学
Eur J Endocrinol. 2020 Jul;183(1):E1-E2. doi: 10.1530/EJE-20-0386.
2
Promoting Medical Students' Interest in Pediatric Endocrinology During COVID-19.在新冠疫情期间提高医学生对儿科内分泌学的兴趣
Clin Pediatr (Phila). 2020 Nov;59(13):1219. doi: 10.1177/0009922820944397. Epub 2020 Jul 17.
3
[Healthcare in the context of Covid-19].
J Fr Ophtalmol. 2020 May;43(5):381-382. doi: 10.1016/j.jfo.2020.04.005. Epub 2020 Apr 20.
4
[When COVID-19 meets the African health service].当新冠病毒遇上非洲医疗服务
Tidsskr Nor Laegeforen. 2020 Apr 6;140(7). doi: 10.4045/tidsskr.20.0283. Print 2020 May 5.
5
Facilitating timely cancer care in a surgical oncology subspecialty unit during the pandemic and recovery phase of the COVID era.在新冠疫情时代的大流行和恢复期，在外科肿瘤亚专科单位促进及时的癌症护理。
Asian J Surg. 2020 Sep;43(9):965-966. doi: 10.1016/j.asjsur.2020.07.005. Epub 2020 Jul 23.
6
[Not Available].
Rev Med Suisse. 2020 Jul 1;16(699):1319-1321.
7
Revamping Outpatient Care for Patients Without COVID-19.改善非新冠肺炎患者的门诊护理。
Mayo Clin Proc. 2020 Sep;95(9S):S44-S46. doi: 10.1016/j.mayocp.2020.06.010. Epub 2020 Jun 20.
8
Revamping Inpatient Care for Patients Without COVID-19.为非新冠病毒肺炎患者改进住院护理。
Mayo Clin Proc. 2020 Sep;95(9S):S41-S43. doi: 10.1016/j.mayocp.2020.06.055. Epub 2020 Jul 30.
9
Leading through COVID-19 crisis.引领应对新冠疫情危机。
Tunis Med. 2020 Apr;98(4):318-319.
10
COVID-19: impact on cancer workforce and delivery of care.新型冠状病毒肺炎：对癌症医疗人力及医疗服务提供的影响
Lancet Oncol. 2020 May;21(5):633. doi: 10.1016/S1470-2045(20)30240-0. Epub 2020 Apr 21.
引用本文的文献
1
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool.糖皮质激素过多或不足患者感染的易感性和特征：ICARO 工具。
Eur J Endocrinol. 2022 Oct 13;187(5):719-731. doi: 10.1530/EJE-22-0454. Print 2022 Nov 1.
2
Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic.在 COVID-19 大流行期间患有垂体疾病患者的重要管理注意事项。
Endocr Pract. 2020 Aug;26(8):915-922. doi: 10.4158/EP-2020-0308.
3
Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis.生长激素缺乏症、肢端肥大症与2019冠状病毒病：从媒体报道到知识及生长激素假说的转变
Growth Horm IGF Res. 2021 Feb;56:101363. doi: 10.1016/j.ghir.2020.101363. Epub 2020 Nov 13.
4
Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Center.COVID-19 时的肾上腺功能不全：三级中心就诊患者的回顾性研究。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1354-e1361. doi: 10.1210/clinem/dgaa793.
5
Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues.2019冠状病毒病大流行期间的生长激素治疗：依从性和药物供应问题。
Eur J Endocrinol. 2020 Oct;183(4):L13-L15. doi: 10.1530/EJE-20-0481.
Zotero 插件